Back to top
more

Better trading starts here.

Brokerage Reports

Research for ABBV

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

1 item in cart

View Cart/Checkout

AbbVie Inc. [ABBV]

Reports for Purchase

Showing records 61 - 80 ( 381 total )

Company: AbbVie Inc.

Industry: Large Cap Pharmaceuticals

Record: 61

07/17/2023

Financial Spreadsheet

Pages: 3

Company Model

Provider: Zacks Investment Research

Analyst: GANORIA S

Price: .00

Research Provided by a Third Party

Company: AbbVie Inc.

Industry: Large Cap Pharmaceuticals

Record: 62

07/17/2023

Company Report

Pages: 12

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: AbbVie Inc.

Industry: Large Cap Pharmaceuticals

Record: 63

07/14/2023

Industry Report

Pages: 47

Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended July 7

Provider: Wedbush Securities Inc.

Analyst: NIERENGARTEN D

Price: 50.00

Research Provided by a Third Party

Company: AbbVie Inc.

Industry: Large Cap Pharmaceuticals

Record: 64

07/11/2023

Company Report

Pages: 6

Optimized Entry and Exit Levels for ABBV 71123

Provider: Stock Traders Daily

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: AbbVie Inc.

Industry: Large Cap Pharmaceuticals

Record: 65

07/07/2023

Industry Report

Pages: 47

Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended June 30.

Provider: Wedbush Securities Inc.

Analyst: NIERENGARTEN D

Price: 50.00

Research Provided by a Third Party

Company: AbbVie Inc.

Industry: Large Cap Pharmaceuticals

Record: 66

06/30/2023

Industry Report

Pages: 47

Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended June 23.

Provider: Wedbush Securities Inc.

Analyst: NIERENGARTEN D

Price: 50.00

Research Provided by a Third Party

Company: AbbVie Inc.

Industry: Large Cap Pharmaceuticals

Record: 67

06/27/2023

Company Report

Pages: 12

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: AbbVie Inc.

Industry: Large Cap Pharmaceuticals

Record: 68

06/20/2023

Company Report

Pages: 12

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: AbbVie Inc.

Industry: Large Cap Pharmaceuticals

Record: 69

05/24/2023

Company Report

Pages: 12

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: AbbVie Inc.

Industry: Large Cap Pharmaceuticals

Record: 70

05/12/2023

Industry Report

Pages: 47

Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended May 5.

Provider: Wedbush Securities Inc.

Analyst: NIERENGARTEN D

Price: 50.00

Research Provided by a Third Party

Company: AbbVie Inc.

Industry: Large Cap Pharmaceuticals

Record: 71

05/05/2023

Industry Report

Pages: 47

Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended April 28.

Provider: Wedbush Securities Inc.

Analyst: NIERENGARTEN D

Price: 50.00

Research Provided by a Third Party

Company: AbbVie Inc.

Industry: Large Cap Pharmaceuticals

Record: 72

04/14/2023

Industry Report

Pages: 47

Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended April 7.

Provider: Wedbush Securities Inc.

Analyst: NIERENGARTEN D

Price: 50.00

Research Provided by a Third Party

Company: AbbVie Inc.

Industry: Large Cap Pharmaceuticals

Record: 73

04/12/2023

Company Report

Pages: 12

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: AbbVie Inc.

Industry: Large Cap Pharmaceuticals

Record: 74

04/11/2023

Company Report

Pages: 6

Optimized Entry and Exit Levels for ABBV 41123

Provider: Stock Traders Daily

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: AbbVie Inc.

Industry: Large Cap Pharmaceuticals

Record: 75

04/10/2023

Industry Report

Pages: 47

Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended March 31.

Provider: Wedbush Securities Inc.

Analyst: NIERENGARTEN D

Price: 50.00

Research Provided by a Third Party

Company: AbbVie Inc.

Industry: Large Cap Pharmaceuticals

Record: 76

04/01/2023

Company Report

Pages: 6

Optimized Entry and Exit Levels for ABBV 4123

Provider: Stock Traders Daily

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: AbbVie Inc.

Industry: Large Cap Pharmaceuticals

Record: 77

03/21/2023

Company Report

Pages: 6

Optimized Entry and Exit Levels for ABBV 32123

Provider: Stock Traders Daily

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party

Company: AbbVie Inc.

Industry: Large Cap Pharmaceuticals

Record: 78

03/17/2023

Industry Report

Pages: 47

Weekly Retail Sales Tracker for Hem. Malignancies - Week Ended March 10.

Provider: Wedbush Securities Inc.

Analyst: NIERENGARTEN D

Price: 50.00

Research Provided by a Third Party

Company: AbbVie Inc.

Industry: Large Cap Pharmaceuticals

Record: 79

03/13/2023

Company Report

Pages: 12

Provider: Zacks Investment Research

Analyst: Research Department

Price: 24.95

Research Provided by a Third Party

Company: AbbVie Inc.

Industry: Large Cap Pharmaceuticals

Record: 80

03/11/2023

Company Report

Pages: 6

Optimized Entry and Exit Levels for ABBV 31123

Provider: Stock Traders Daily

Analyst: Research Department

Price: 12.50

Research Provided by a Third Party